Carl J. Simpson

Kerberos Proximal Solutions, Inc. is a medical device company. It develops solutions to treat vascular disease. The company develops proximal embolic-protection technology to recover debris dislodged during angioplasty and stent placement Investors. Kerberos Proximal Solutions was founded in 2001 and is headquartered in Cupertino, CA

Uptake Medical Corp. develops medical technologies for the treatment of lung diseases. It provides InterVapor, an endoscopic lung volume reduction solution for people with severe emphysema that uses the body’s natural healing process without leaving implants or foreign materials in the lung; and InterVapor Personalized Procedure Program, a proprietary application that recommends treatment locations and ablation energy durations for each patient based on the patient’s CT scan. The company was founded by Robert L. Barry in 2004 and is headquartered in Tustin, CA.

Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver.

Guidant Corp. manufactures cardiovascular therapeutic devices. The company also provides cardiac and peripheral vascular repair surgical systems. It operates in Europe and Japan. Guidant was founded in 1994 and is headquartered in St. Paul, MN.

Conor Medsystems LLC develops vascular drug delivery technologies. Its products include controlled vascular drug delivery technologies and novel stent that are used in the treatment of coronary artery disease and delivery of a broad spectrum of therapeutic agents. The company was founded by John F. Shanley in 1999 and is headquartered in Menlo Park, CA.

Coronis Medical Ventures LLC (Coronis Medical Ventures) is a venture capital firm founded in 2006. The firm is headquartered in Sunnyvale, California.

Norborn Medical, Inc. develops medical devices. The firm's devices are used to combat chronic total occlusions or blockages of failed angioplasty surgeries. The company was founded by Gerardo Noriega in 1999 and is headquartered in Mountain View, CA.

ReVascular Therapeutics, Inc. used to develop and manufacture medical devices. It offers TRUEPATH, an intraluminal chronic total occlusion crossing device enabling endovascular treatment in cases that typically cannot be treated with standard endovascular devices. The company was founded in 2006 by Carl Simpson, Menahem Nassi and Gerardo V. Noriega and is headquartered in Sunnyvale, CA.